Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Cytosorbents (CTSO) Receivables - Net (2016 - 2025)

Cytosorbents (CTSO) has disclosed Receivables - Net for 14 consecutive years, with $7.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 11.98% year-over-year to $7.4 million, compared with a TTM value of $7.4 million through Sep 2025, up 11.98%, and an annual FY2024 reading of $7.3 million, up 20.85% over the prior year.
  • Receivables - Net was $7.4 million for Q3 2025 at Cytosorbents, down from $7.7 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $7.8 million in Q2 2024 and bottomed at $4.5 million in Q4 2021.
  • Average Receivables - Net over 5 years is $6.2 million, with a median of $6.1 million recorded in 2023.
  • Peak annual rise in Receivables - Net hit 47.92% in 2021, while the deepest fall reached 12.32% in 2021.
  • Year by year, Receivables - Net stood at $4.5 million in 2021, then grew by 25.24% to $5.7 million in 2022, then grew by 6.92% to $6.1 million in 2023, then increased by 20.85% to $7.3 million in 2024, then rose by 1.46% to $7.4 million in 2025.
  • Business Quant data shows Receivables - Net for CTSO at $7.4 million in Q3 2025, $7.7 million in Q2 2025, and $7.7 million in Q1 2025.